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Incidence, presentation, diagnosis, and 
management of malfunctioning implantable 
cardioverter-defibrillator rate-sensing leads 
Recognition of tachyarrhythmia by an implantable cardioverter-defibrillator (ICD) requires an 
intact rate-sensing lead. We retrospectively examined 266 consecutive patients requiring an ICD 
to characterize the incidence, clinical presentation, diagnosis, and management of a defective 
rate-sensing lead. To identify clinical parameters that may contribute to lead complications, we 
also assessed the effects of age, gender, type of rate-sensing lead, manufacturer of the lead, 
and surgeon. Over a follow-up period of 30 2 22 months (mean + standard deviation), a 
defective lead was found in 9 (3.4%) patients, in 9 (1.7%) of 514 leads over a period of 2 to 39 
(mean 17 + 15) months after implantation. Except for 1 patient, in whom a lead fracture was 
incidently found during ICD generator replacement, these patients had multiple inappropriate 
shocks of recent onset. Clinical parameters were not helpful in identifying patients at risk for 
lead complication. An abnormal beeping signal obtained while the patients performed various 
maneuvers was helpful in confirming a defect. Ail of the defective leads were epicardial. These 
cases were managed by placement of a transvenous endocardiai lead. (AM HEART J 
1994;128:892-5.) 
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Recognition of ventricular tachyarrhythmias by an 
implantable cardioverter-defibrillator (ICD) de- 
pends primarily on sensing the rate of the arrhyth- 
mia. Therefore accurate rate-counting is fundamen- 
tal to proper function of the ICD system. Rate- 
counting is achieved by the rate-sensing circuit of the 
device, which uses either a transvenous coaxial lead 
within the right ventricle or a pair of unipolar 
screw-in leads placed on the epicardium. Although 
previous studies have reported defective rate-sensing 
leads,ld4 the clinical profile of patients in whom lead 
complications occur has not been investigated. The 
purpose of this study was to describe the incidence, 
clinical presentation, diagnosis, and management of 
ICD malfunction attributable to a defective rate- 
sensing lead. 
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METHODS 
Study population. The study population consisted of 
266 consecutive patients who underwent implantation of 
an ICD at the University of Michigan Hospital or the Ann 
Arbor Veterans Affairs Medical Center between March 
1987 and July 1992. There were 218 men and 48 women. 
Their mean age was 60 t 22 years (mean rt_ SD). The un- 
derlying heart disease consisted of coronary artery disease 
in 202 (76 %), idiopathic cardiomyopathy in 41 (15 % ), val- 
vular heart disease in 11 (4%), other heart disease in 4 
(2 % ), and no identifiable heart disease in 8 (3 % ). Aborted 
sudden cardiac death with documented ventricular fibril- 
lation (VF) had occurred in 186 patients, and recurrent 
syncope or presyncope caused by ventricular tachycardia 
(VT) had occurred in 80 patients. 
Implantation of rate-sensing lead. All of the ICD pulse 
generators, defibrillation patch electrodes, and transvenous 
rate-sensing leads were manufactured by Cardiac Pace- 
makers, Inc. (St. Paul, Minn.). The myocardial screw-in 
rate-sensing leads were manufactured by Cardiac Pace- 
makers, Inc. and Daig, Inc. (Minnetonka, Minn.). In 248 
patients, a pair of myocardial screw-in leads was used for 
rate sensing. These leads and a pair of defibrillation patch 
electrodes were placed on the epicardium through a median 
sternotomy. The myocardial leads were placed on the sur- 
face of the right ventricular anterior wall in 242 patients 
and on the left ventricular lateral wall in 6 patients who al- 
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ready had a cardiac pacemaker lead within the right ven- 
tricle. A transvenous endocardial rate-sensing lead was in- 
serted in 18 patients in whom an epicardial defibrillation 
patch electrode was placed through a left thoracotomy. The 
transvenous rate-sensing lead and spring coil lead were in- 
serted into a subclavian vein and positioned in the right 
ventricular apex and at the right atrial-superior vena caval 
junction. 
Placement of implantable cardioverter defibrillator 
generator. After an acceptable VF defibrillation threshold 
had been confirmed, the proximal portions of the leads 
were pulled through a subcutaneous tunnel to the ICD 
pocket in the left subcostal area. ICDs capable only of de- 
livering shocks were used in 261 patients; ICDs also capa- 
ble of antitachycardia pacing were used in 5 patients. Be- 
fore discharge from the hospital, the ICD was tested to 
confirm reliable sensing and conversion of VT and VF. 
Patient follow-up. After discharge, the patients were 
seen in an outpatient clinic every 2 or 3 months during the 
first year after implantation and every 1 to 3 months 
thereafter. For each ICD shock, the presence or absence of 
syncope or other symptoms was recorded. The shocks were 
confirmed by the programmer during each visit. In patients 
in whom frequent ICD discharges occurred, outpatient or 
in-hospital electrocardiographic monitoring was performed 
to determine whether arrhythmias were triggering the dis- 
charges. These patients also were asked to bend and twist 
at the waist, reach up with their arms, cough, and perform 
Valsalva’s maneuver after a magnet had been positioned 
over the pulse generator to detect abnormal beeping 
signals. Audible tones not corresponding to a QRS complex 
on a simultaneous electrocardiogram indicated a malfunc- 
tioning of the ICD sensing system. This finding prompted 
exploration of the ICD pocket to evaluate directly the 
rate-sensing leads. The evaluation consisted of careful vi- 
sual examination of the lead and measurement of the pac- 
ing threshold and lead impedance. If either or both of these 
measurements were abnormal, the lead was considered de- 
fective and a new lead implanted. 
Statistical analysis. Continuous variables are expressed 
as the mean r SD. Differences between continuous vari- 
ables were tested by Student’s t test, and differences 
between categorical variables were tested by chi square 
analysis. A p value <0.05 was considered significant. 
RESULTS 
Incidence of defective leads. Of 496 epicardial and 
18 endocardial rate-sensing leads, a defect was found 
in 9 (1.7 % ) epicardial leads in 9 (3.4 % ) patients over 
a period of 30 + 22 months of follow-up. The dura- 
t.ion from implantation to presentation of the defec- 
tive lead was 17 k 15 (range 2 to 39) months. Lead 
malfunction occurred in 5 patients within the first 
year, in one patient in the second year, in one patient 
in the third year, and in two patients in the fourth 
year after implantation. Analysis of selected clinical 
parameters including gender, age, type of lead (trans- 
venous endocardial vs screw-in epicardial), manufac- 
Table I. Comparison of clinical profile of patients with and 
without a defective rate-sensing lead 
Patients without Patients with 
defective leads defective leads 
(n = 2.57: in = 9) 
Age (yr, mean t SD) 
Male 



















60 + 10 






p > 0.05 for all comparisons. 
turer, and surgeon indicated that there were no sig- 
nificant differences between the patients with and 
those without a defective lead (Table I). 
Clinical manifestations and diagnosis of lead mal- 
function. Eight patients initially had frequent ICD 
discharges of recent onset (shocks in seven patients 
and shocks and antitachycardia pacing in one) that 
were not preceded by any symptoms and that oc- 
curred during minimal body movement (Table II). 
Holter or in-hospital telemetric electrocardiographic 
monitoring documented that ICD shocks were deliv- 
ered during sinus rhythm in five patients. Inappro- 
priate rate-sensing was confirmed by abnormal beep- 
ing signals in these eight patients. Chest and abdom- 
inal radiographs were obtained in seven patients, and 
in none was a fracture line in a lead seen. With direct 
evaluation of the leads in five patients, a high imped- 
ance (>lOOO Q) and a pacing threshold of >lO V were 
found in four patients, and a fracture line was visu- 
ally noted at the neck of the lead near the ICD con- 
nector in the fifth patient. In the ninth patient, a 
fracture line was seen incidentally at the neck of the 
lead near the ICD connector during pulse generator 
replacement. Multiple ICD shocks had never oc- 
curred in this patient before the replacement. In none 
of these patients was there a loose screw cap or a loose 
connection in the header slots. 
Management and follow-up. In all patients, the lead 
defect was managed by implanting a transvenous en- 
docardial rate-sensing lead in the right ventricular 
apex via the left subclavian vein. The lead was then 
tunneled subcutaneously to the ICD pulse generator. 
Normal sensing was later confirmed by the absence 
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Table II. Clinical profile of patients in whom rate-sensing lead was defective 
Time since 
Age implantation Beeping 












49 13 15 Shocks in 9 days; 
Holter monitor 
documentation of 
shocks during sinus 
rhythm 















7 Shocks and 7 
antitachycardia 
pacing in 2 days 
6 Shocks in 10 days; 
Holter monitor 
documention of 
shocks during sinus 
rhythm 
4 Shocks in 4 days 
10 Shocks in 36 hours; 
telemetric monitor 
documentation of 
shocks during sinus 
rhythm 
4 Shocks in 1 wk; 
Holter monitor 
documentation of 
shocks during sinus 
rhythm 
7 Shocks in 3 mo; 
Holter monitor 
documentation of 
shocks during sinus 
rhythm 
None 
Abnormal No shock in 13 mo 
Abnormal High pacing 
threshold (>lO V) 
and impedance 
(>1600 n) 
Abnormal Fracture line at neck 
Abnormal High pacing 
threshold (>lO V) 
and inpedance 
(>lOOO St) 
Abnormal High pacing 




Abnormal High pacing 
threshold (>lO V) 
and impedance 
(>lOOO Q) 
No shock in 3 mo 
Abnormal No shock in 12 mo 
Not done Fracture line at neck No shock in 23 mo 
No shock in 3 mo 
1 Shock in 8 mo 
No shock in 4 mo 
No shock in 6 mo 
4 Shocks in 28 mo 
of an abnormal beeping signal during various body 
movements. The defective leads were capped and left 
in place. During a mean follow-up of 11 +- 9 months 
after implantation of the new rate-sensing lead, seven 
patients had no recurrence of ICD discharges. One 
patient had one shock in 8 months, and another pa- 
tient had four shocks in 28 months. These events 
were sporadic and usually preceded by symptoms 
consistent with VT or VF. 
DISCUSSION 
During a mean postimplantation interval of 30 
months, in 3.4% of patients with an ICD, or 9 (1.7 % 1 
of 512 leads, the rate-sensing lead malfunctioned. 
The most common clinical manifestation of lead 
malfunction was the occurrence of multiple inappro- 
priate ICD discharges. The interval from implanta- 
tion to detection of lead malfunction was 2 to 39 
months. 
Previous reports. A malfunctioning rate-sensing 
lead causing inappropriate ICD discharges is a well- 
recognized complication of ICD therapy. The inci- 
dence has been reported to be 0.7 % to 3.8% .im4 The 
1.7% incidence of lead malfunction in the present 
study is consistent with those results. 
Diagnosis. Except for the incidental discovery of a 
fractured lead during ICD pulse generator replace- 
ment in one patient, all patients had recent multiple 
ICD discharges that were not preceded by symptoms 
and that occurred during activities such as walking, 
sitting up, and arm-stretching. Because most cur- 
rently available ICD devices do not have electrogram 
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storage capability and because appropriate shocks 
are not necessarily preceded by symptoms,5 the 
diagnosis of a defective rate-sensing lead depends 
primarily on close, continuous observation. A sudden 
increase in the frequency of ICD discharges in a pa- 
tient with a stable clinical course may indicate lead 
malfunction and should prompt an evaluation of the 
integrity of the rate-sensing lead. It is also important 
to check the functional specifications of the leads at 
the time of pulse generator replacement. Without 
that check, the diagnosis of a lead fracture in one pa- 
tient in this series may have been delayed. 
Other investigators6* 7 have evaluated the useful- 
ness of the “beep-o-gram” to detect malfunctioning 
of the ICD-sensing system. Ballas et a1.7 concluded 
that it is a reliable and sensitive means of detecting 
sensing abnormalities, as was the case in the present 
study. It is important to ask the patient to perform 
simple exercises (e.g., sitting up or bending and 
stretching at the waist) during the evaluation because 
beep monitoring performed only at rest may not de- 
tect a defective lead. 
Cause of lead malfunction. Fracture was the cause of 
lead malfunction in five patients-one confirmed by 
direct visualization of a fracture line, three by the 
presence of a high lead impedance, and one by direct 
visualization of a fracture line and high lead imped- 
ance. In the remaining three patients, the cause was 
unknown. The ICD sensing circuit was not the source 
of excessive sensing in these three patients: the same 
pulse generator was used after placement of a new 
lead, and inappropriate shocks did not recur. The two 
leads that had a visible fracture line had fractured at 
the same site, the neck of the lead. It is possible that 
this location is vulnerable to damage caused by the 
traction used to pull the lead subcutaneously to the 
generator during implantation. Therefore it may be 
important to avoid applying excessive traction when 
tunneling the leads to the generator pocket. 
Potential proarrhythmic complications. Although no 
proarrhythmic complication of the inappropriate 
shocks was observed in this study, several reports 
have documented the induction of malignant ven- 
tricular tachyarrhythmias by an R-wave-synchro- 
nized ICD shock delivered during sinus tachycardia 
or supraventricular tachyarrhythmias.s-lo In these 
Daoud et al. 995 
case reports, the ICD was able to detect the induced 
ventricular tachyarrhythmia and to deliver rescue 
shocks. However, Cohen et al.” reported a case in 
which subsequent shocks failed to restore sinus 
rhythm. Because a defective rate-sensing lead often 
causes the ICD pulse generator to discharge during 
sinus rhythm, patients are exposed to an unnecessary 
additional risk of malignant ventricular tachyar- 
rhythmias and of syncope or even death. Therefore, 
physicians should consider a rate-sensing lead com- 
plication in patients who have frequent ICD dis- 
charges. 
We thank Penny Weaver for excellent secretarial assistance in 









Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. 
Clinical experience, complications and survival in 70 patients with the 
automatic implantable cardioverter/defibrillator. Circulation 1985;71: 
289-96. 
Kelly PA, Cannom DS, Garan H, Mirabal GS, Harthome JW, Hurvitx 
RJ, Vlahakes GJ, Jacobs ML, Ilvento JP, Buckley MJ, Ruskin JN. The 
automatic implantable cardioverter-defibrillator: efficacy, complica- 
tions and survival in patients with malignant ventricular arrhythmias. 
J Am Co11 Cardiol 1988;11:1278-86. 
Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, 
Schmidt P, Shipman T. Long-term outcome with the automatic 
implantable cardioverter-defibrillator. J Am Co11 Cardiol 1989;6:1353- 
61. 
Marchlinski FE, Flares BT, Buxton AE, Hargrove WC, Addonixio VP, 
Stephenson LW, Harken AH, Doherty JU, Grogan EW, Josephson ME. 
The automatic implantable cardioverter-defibrillator: efficacy, compli- 
cations, and device failures. Ann Intern Med 1986;104:481-8. 
Tchou PJ, Kadri N, Anderson J, Caceres JA, dasayeri M, Akhtar M. 
Automatic implantable cardioverter defibrillator survival of patients 
with left ventricular dysfunction and malignant ventricular arrhyth- 
mias. Ann Intern Med 1988,109:529-34. 
Chapman PD. Troup P. The automatic implantable cardioverter- 
defibrillator: evaluating suspected inappropriate shocks, d Am Co11 
Cardiol 1986;7:1075-8. 
Ballas SJ, Rashidi R, McAlister H, Corbelli R, McGowan R, Wilkoff BL, 
Castle LW, Morant VA, Simmons TW, Maloney JD. The use of beep- 
o-grams in the assessment of automatic implantable cardioverter 
defibrillator sensing function. PACE 1989;12:1737-45. 
8. Cohen TJ, Chien WW, Lurie KG, Lee MA, Lesh MD, Scheinman MM, 
Griffin JC. Implantable cardioverter defibrillator pro-arrhythmia: case 
report and review of the literature. PACE 1991;14:1326-9. 
9. Kou WH, Kirsh MM, Stirling MC, Kadish AH, Orringer CE, Morady 
F. Provocation of ventricular tachycardia by an automatic implantable 
cardioverter defibrillator. AM HEART J 1990;120:208-11. 
10. Manx M, Gerckens U, Luderitz B. Erroneous discharge from an 
implanted automatic defibrillator during supraventricular tachyar- 
rhythmia induced ventricular fibrillation. Am ,I Cardiol 1986;57:343-4. 
